The UK’s first dedicated facility for clinical trials using pioneering neurotechnologies has been launched in Newcastle, marking a major milestone in neurological research and treatment.
The National Centre for Neurotechnology and Neurorestoration, hosted by Newcastle Hospitals in collaboration with Newcastle University, will focus on implanted devices placed in or near the brain and nervous system to restore function and improve health.
Specialising in cutting-edge technologies such as brain-computer interfaces (BCIs) and neurostimulators, the centre will explore advanced treatments for a wide range of disabling neurological conditions affecting movement, sensation, mood, and cognition.
Mr Akbar Hussain, Clinical Director, commented:
“Through the rapid rise and pace of development in modern neurotechnologies, and advances in artificial intelligence, we are entering a new era in treating disorders of the brain and nervous system.
“In Newcastle we have a track record of successful clinical trials in this specialist field and I’m excited to be involved in taking this to the next level.
“The centre will allow us to strengthen and grow our capacity and skills to meet demand and will mean we can pave the way for a future standard of care in neurological disorders, allowing more life-changing treatments to be brought to patients.”
The centre will:
- Provide safe access to clinical trials for people living with neurological conditions
- Drive scientific research to deepen understanding of the human brain and expand neurotechnology potential
- Act as a national hub to accelerate neurotechnology projects, supporting UK and international academic and industry partners
Scientific Director Dr Luke Bashford also said:
“The national centre has been formed to meet a breakthrough moment in human neuroscience.
“The neurotechnology device industry is burgeoning and seeking expert healthcare partners, and the scientific community is entering a period of unprecedented scale of access to the human brain for research.
“The centre will provide all stakeholders with the academic, regulatory, and clinical support to ensure that there are no delays to performing the full spectrum of UK neurotechnology work.
“We will lead and facilitate scientific research and clinical trials that will revolutionise our understanding of the human brain and allow individuals with complex neurological conditions to manage symptoms and regain abilities that would otherwise be unthinkable.”
By creating a dedicated national facility, the centre will enable the health service to deliver today’s studies faster and adapt quickly to future innovations, ensuring patients benefit from the latest breakthroughs in neurotechnology.
Image credit: iStock
